EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Distinct molecular profile and outcome of oligodendroglioma, IDH -mutant, 1p/19q-codeleted, and TERT p-wildtype: A grade 1 oligodendroglioma of young patients?

Filippo Nozzoli iD, Ramin Rahmanzade, Simone Schmid iD, Leonille Schweizer, Daniel Schrimpf, Dennis Friedel iD, Kirsten Göbel, David E Reuss, Rouzbeh Banan, Philipp Sievers iD, Stefan Pusch, Henri Bogumil und 31 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Filippo Nozzoli und 42 weiteren Autor:innen. Beteiligte Einrichtung: Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy. Hauptthemen laut MEDLINE: Oligodendroglioma, Telomerase, Isocitrate Dehydrogenase, Chromosomes, Human, Pair 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oligodendrogliomas, characterized by isocitrate dehydrogenase (IDH) mutations and 1p/19q codeletion, often exhibit telomerase reverse transcriptase promoter (TERTp) mutations, which have been linked to telomere maintenance (TM) and tumor proliferation. Although there are a few reports on a TERTp-wildtype subset of these tumors in adolescents and young adults, the frequency, molecular characteristics, and prognostic implications of TERTp-wildtype status in oligodendrogliomas remain elusive.

Methods

We retrospectively analyzed 166 IDH-mutant and 1p/19q-codeleted oligodendroglioma cases through comprehensive histopathological review and molecular analyses, including Sanger sequencing, DNA methylation profiling, and whole-exome sequencing (WES).

Results

A TERTp-wildtype status was observed in 20/166 cases (12.0%) and was significantly associated with noticeably young age (age range: 14–27, P < .001), CNS WHO grade 2 (P = .003), and the absence of additional DNA copy number variations (CNVs) beyond the pathognomonic 1p/19q codeletion (P < .001). Epigenetic profiling demonstrated TERTp-wildtype tumors shaped a distinct subgroup at the utmost periphery of TERTp-mutant oligodendrogliomas. Methylation analysis of the upstream and proximal TERTp regions revealed that, in line with the absence of genetic alterations, epigenetic regulation does not favor TERT overexpression in TERTp-wildtype oligodendrogliomas. WES showed no TM-related gene alterations in TERTp-wildtype cases. Cox regression analysis confirmed TERTp-wildtype status as an independent prognostic factor for more favorable progression-free survival (PFS) (P = .009).

Conclusions

In conclusion, “oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype” represent a distinct molecular subgroup associated with younger age and a better clinical course compared to CNS WHO grade 2 oligodendrogliomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OligodendrogliomaTelomeraseIsocitrate DehydrogenaseChromosomes, Human, Pair 1Chromosomes, Human, Pair 19Brain NeoplasmsMutationBiomarkers, TumorHumansAdolescentFemaleMaleAdultYoung AdultRetrospective StudiesPrognosisChromosome DeletionDNA MethylationPromoter Regions, GeneticFollow-Up StudiesSurvival RateNeoplasm GradingDNA Copy Number Variations

Stichwörter der Autor:innen

TERT promoteradolescents and young adultsmethylationoligodendrogliomaprogression-free survival

Substanzen

TelomeraseIsocitrate DehydrogenaseTERT protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy.
  • Section of Anatomic Pathology, Department of Health Sciences, University of Florence, Florence, Italy.
  • Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Institute of Pathology, Ludwig Maximilians University Hospital Munich, Munich, Germany.
  • German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

ORCID-Profile: Filippo Nozzoli, Simone Schmid, Dennis Friedel, Philipp Sievers, Felix Hinz, Alessia Andrea Ricci, Sabrina Zechel, Christine Stadelmann, Jens Schittenhelm, Miriam Ratliff, Christel Herold-Mende, Stefan M Pfister, Wolfgang Wick, Andreas von Deimling, Felix Sahm, Luca Bertero

Zitieren

APA

Nozzoli, F., Rahmanzade, R., Schmid, S., Schweizer, L., Schrimpf, D., Friedel, D., Göbel, K., Reuss, D. E., Banan, R., Sievers, P., Pusch, S., Bogumil, H., Hinz, F., Suwala, A. K., Aras, F. K., Friedrich, L., Osella-Abate, S., Ricci, A. A., Macciotta, A., …, & Bertero, L. (2025). Distinct molecular profile and outcome of oligodendroglioma, IDH -mutant, 1p/19q-codeleted, and TERT p-wildtype: A grade 1 oligodendroglioma of young patients?. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf141

Vancouver

Nozzoli F, Rahmanzade R, Schmid S, Schweizer L, Schrimpf D, Friedel D, et al. Distinct molecular profile and outcome of oligodendroglioma, IDH -mutant, 1p/19q-codeleted, and TERT p-wildtype: A grade 1 oligodendroglioma of young patients?. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf141

BibTeX
@article{Nozzoli2025,
  author = {Nozzoli, Filippo and Rahmanzade, Ramin and Schmid, Simone and Schweizer, Leonille and Schrimpf, Daniel and Friedel, Dennis and Göbel, Kirsten and Reuss, David E and Banan, Rouzbeh and Sievers, Philipp and Pusch, Stefan and Bogumil, Henri and Hinz, Felix and Suwala, Abigail K and Aras, Fuat Kaan and Friedrich, Lukas and Osella-Abate, Simona and Ricci, Alessia Andrea and Macciotta, Alessandra and Simon, Thorsten and Fleischhack, Gudrun and Keyvani, Kathy and Hansford, Jordan R and Khuong-Quang, Dong-Anh and Schucht, Philippe and Maragkou, Theoni and Juratli, Tareq A and Meinhardt, Matthias and Zechel, Sabrina and Stadelmann, Christine and Coras, Roland and Sakowitz, Oliver W and Goeppert, Benjamin and Schittenhelm, Jens and Etminan, Nima and Ratliff, Miriam and Herold-Mende, Christel and Pfister, Stefan M and Wick, Wolfgang and Krieg, Sandro M and von Deimling, Andreas and Sahm, Felix and Bertero, Luca},
  title = {Distinct molecular profile and outcome of oligodendroglioma, IDH -mutant, 1p/19q-codeleted, and TERT p-wildtype: A grade 1 oligodendroglioma of young patients?},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf141}
}
Kostenlos starten →